JP2020514299A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020514299A5 JP2020514299A5 JP2019536976A JP2019536976A JP2020514299A5 JP 2020514299 A5 JP2020514299 A5 JP 2020514299A5 JP 2019536976 A JP2019536976 A JP 2019536976A JP 2019536976 A JP2019536976 A JP 2019536976A JP 2020514299 A5 JP2020514299 A5 JP 2020514299A5
- Authority
- JP
- Japan
- Prior art keywords
- chemical formula
- solvate
- hydrate
- structure represented
- following chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)C*C(*)(*)SSC*(*)C*CN(*)CIC(CON)CON Chemical compound CC(C)C*C(*)(*)SSC*(*)C*CN(*)CIC(CON)CON 0.000 description 3
- ANZUADGNOKSXOB-UHFFFAOYSA-N CCOc1ccc(C(CC2)C(CC3)C(CC4)C2(C)C4OCCCOC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c3c1 Chemical compound CCOc1ccc(C(CC2)C(CC3)C(CC4)C2(C)C4OCCCOC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c3c1 ANZUADGNOKSXOB-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762443822P | 2017-01-09 | 2017-01-09 | |
| US62/443,822 | 2017-01-09 | ||
| PCT/IL2018/050031 WO2018127927A1 (en) | 2017-01-09 | 2018-01-09 | Compounds and methods for trans-membrane delivery of molecules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020514299A JP2020514299A (ja) | 2020-05-21 |
| JP2020514299A5 true JP2020514299A5 (enExample) | 2021-02-18 |
| JP7348064B2 JP7348064B2 (ja) | 2023-09-20 |
Family
ID=62789169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536976A Active JP7348064B2 (ja) | 2017-01-09 | 2018-01-09 | 分子を経膜送達するための化合物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11230710B2 (enExample) |
| EP (1) | EP3565603B1 (enExample) |
| JP (1) | JP7348064B2 (enExample) |
| KR (1) | KR20190104392A (enExample) |
| CN (1) | CN110402152B (enExample) |
| AU (1) | AU2018205898B2 (enExample) |
| CA (1) | CA3049640A1 (enExample) |
| EA (1) | EA201991661A1 (enExample) |
| IL (1) | IL267919B2 (enExample) |
| WO (1) | WO2018127927A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11318206B2 (en) | 2014-03-28 | 2022-05-03 | Aposense Ltd | Compounds and methods for trans-membrane delivery of molecules |
| EP3565603B1 (en) | 2017-01-09 | 2022-12-07 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| US10195286B2 (en) * | 2017-07-04 | 2019-02-05 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| JP2021509406A (ja) * | 2018-01-01 | 2021-03-25 | アポセンス リミテッドＡｐｏｓｅｎｓｅ Ｌｔｄ． | 分子の膜貫通送達のための化合物および方法 |
| WO2020044349A1 (en) * | 2018-08-30 | 2020-03-05 | Aposense Ltd. | Compounds, cojugates and compositions for use in the methods for trans-membrane delivery of molecules |
| JPWO2023022055A1 (enExample) * | 2021-08-17 | 2023-02-23 | ||
| WO2025096244A1 (en) * | 2023-10-30 | 2025-05-08 | Olfera Corporation | Olfactory delivery scaffolds and methods for making and using same |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE345682T1 (de) | 1996-05-01 | 2006-12-15 | Imarx Pharmaceutical Corp | In vitro verfahren zum einbringen von nukleinsäuren in eine zelle |
| US6090800A (en) | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
| AU6974798A (en) | 1997-05-06 | 1998-11-27 | Imarx Pharmaceutical Corp. | Novel prodrugs comprising fluorinated amphiphiles |
| FR2846969A1 (fr) | 2002-11-08 | 2004-05-14 | Salles Jean Pierre | Nouveaux vecteurs moleculaires amphiphiles fluorocarbones a usage biomedical et medical |
| SE527131C2 (sv) | 2004-02-13 | 2005-12-27 | Innoventus Project Ab | Steroider för cancerbehandling |
| DE602005024690D1 (de) | 2004-07-08 | 2010-12-23 | Aposense Ltd | Verfahren und verbindungen zum nachweis von medizinischen erkrankungen |
| MX2007002210A (es) | 2004-08-26 | 2007-05-07 | Nicholas Piramal India Ltd | Profarmacos que contienen enlazantes bioescindibles novedosos. |
| NZ554176A (en) | 2004-10-01 | 2010-04-30 | Prometic Biosciences Inc | Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| BRPI0520032A2 (pt) | 2005-02-18 | 2009-04-14 | Angiochem Inc | moléculas para transportar um composto através da barreira hematoencefálica |
| EP2064223B1 (en) | 2006-09-22 | 2013-04-24 | Dharmacon, Inc. | Duplex oligonucleotide complexes and methods for gene silencing by RNA interference |
| EP3705125B1 (en) | 2007-12-04 | 2023-07-05 | Alnylam Pharmaceuticals, Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
| CA3065577C (en) | 2008-05-13 | 2022-05-31 | Phaserx, Inc. | Diblock copolymers and polynucleotide complexes thereof for delivery into cells |
| WO2009155335A2 (en) | 2008-06-19 | 2009-12-23 | University Of Maryland, Baltimore | Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization |
| CN108165548B (zh) | 2008-09-22 | 2022-10-14 | 菲奥医药公司 | 减小大小的自递送RNAi化合物 |
| US20120035362A1 (en) | 2010-08-03 | 2012-02-09 | Berry And Associates, Inc. | Phosphoramidite derivatives of folic acid |
| GB201122458D0 (en) | 2011-12-30 | 2012-02-08 | Univ Wageningen | Modified cascade ribonucleoproteins and uses thereof |
| FI3597749T3 (fi) | 2012-05-25 | 2023-10-09 | Univ California | Menetelmiä ja koostumuksia rna-ohjattua kohde-dna-modifikaatiota varten ja rna-ohjattua transkription modulaatiota varten |
| KR20150027756A (ko) | 2012-05-30 | 2015-03-12 | 베일러 칼리지 오브 메디신 | Dna 수복, 변경 및 대체를 위한 도구로서의 초나선 미니벡터 |
| HK1212618A1 (zh) | 2012-10-16 | 2016-06-17 | 恩多塞特公司 | 含有非天然氨基酸的藥物遞送綴合物以及其使用方法 |
| US20160002159A1 (en) | 2013-02-13 | 2016-01-07 | Neal ZONDLO | Perfluoro-tert-butyl hydroxyproline |
| CN105873902B (zh) | 2013-11-18 | 2019-03-08 | 阿克丘勒斯治疗公司 | 用于rna递送的可电离的阳离子脂质 |
| US9889202B2 (en) | 2014-03-28 | 2018-02-13 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| WO2015145417A1 (en) | 2014-03-28 | 2015-10-01 | Ilan Ziv | Compounds and methods for trans-membrane delivery of molecules |
| US9993563B2 (en) | 2014-03-28 | 2018-06-12 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| US20160016855A1 (en) * | 2014-07-21 | 2016-01-21 | Benxin Wu | Fabrication of carbon nanotube-nonoxide structural ceramic nanocomposites through laser sintering |
| EP3565603B1 (en) | 2017-01-09 | 2022-12-07 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| US10195286B2 (en) | 2017-07-04 | 2019-02-05 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
-
2018
- 2018-01-09 EP EP18736287.6A patent/EP3565603B1/en active Active
- 2018-01-09 KR KR1020197023505A patent/KR20190104392A/ko not_active Withdrawn
- 2018-01-09 IL IL267919A patent/IL267919B2/en unknown
- 2018-01-09 CN CN201880017053.0A patent/CN110402152B/zh active Active
- 2018-01-09 US US16/476,557 patent/US11230710B2/en active Active
- 2018-01-09 AU AU2018205898A patent/AU2018205898B2/en active Active
- 2018-01-09 EA EA201991661A patent/EA201991661A1/ru unknown
- 2018-01-09 JP JP2019536976A patent/JP7348064B2/ja active Active
- 2018-01-09 WO PCT/IL2018/050031 patent/WO2018127927A1/en not_active Ceased
- 2018-01-09 CA CA3049640A patent/CA3049640A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020514299A5 (enExample) | ||
| JP7075669B2 (ja) | 核酸送達用カチオン性脂質及びその調製物 | |
| Mével et al. | DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA | |
| JP2017061563A5 (enExample) | ||
| JP2019514426A5 (enExample) | ||
| ES2987915T3 (es) | Nuevos lípidos catiónicos de bajo peso molecular para el suministro de oligonucleótidos | |
| JP2016153410A5 (enExample) | ||
| BR112013016761B1 (pt) | Uso de um composto, composto e composição farmacêutica | |
| JP2010521485A5 (enExample) | ||
| JP2012518029A5 (enExample) | ||
| JP2020525502A5 (enExample) | ||
| CA2653941A1 (en) | Substituted amino purine derivatives and uses thereof | |
| JP2022502451A (ja) | 核酸送達のための脂質化カチオン性ペプチド化合物を含む脂質ナノ粒子製剤 | |
| RU2016142510A (ru) | Соединения и способы для транс-мембранной доставки молекул | |
| JP2003511045A (ja) | Ｒｎａ結合化合物の同定方法 | |
| CN114681621A (zh) | 肽寡核苷酸缀合物 | |
| JP2018509143A5 (enExample) | ||
| CN114945556B (zh) | 用于核酸转染的类脂质及其用途 | |
| JP2016535058A5 (enExample) | ||
| JP2021502346A5 (enExample) | ||
| CN111344018B (zh) | 聚乙二醇化卡非佐米化合物的稳定的组合物 | |
| JPWO2021049504A5 (enExample) | ||
| JP2013537404A5 (enExample) | ||
| AU2019260738B2 (en) | Integrin targeting ligands and uses thereof | |
| JP2018527360A5 (enExample) |